{"AllianceGenome": "2608", "HGNC": "2608", "MIM": "608055", "_id": "1553", "_version": 1, "accession": {"genomic": ["AC008962.9", "CH471126.1", "CP068259.2", "NC_000019.10", "NC_060943.1", "NG_007928.1", "U22028.1"], "protein": ["AAB40519.1", "AAG35775.1", "AAR90935.1", "AAR90936.1", "AAR90937.1", "AAR90938.1", "AAR90939.1", "AAR90940.1", "EAW57016.1", "NP_000757.2", "Q16696.3"], "rna": ["AF209774.1", "AY513604.1", "AY513605.1", "AY513606.1", "AY513607.1", "AY513608.1", "AY513609.1", "BM975825.1", "NM_000766.5"], "translation": [{"protein": "AAR90937.1", "rna": "AY513606.1"}, {"protein": "AAR90935.1", "rna": "AY513604.1"}, {"protein": "AAR90939.1", "rna": "AY513608.1"}, {"protein": "AAG35775.1", "rna": "AF209774.1"}, {"protein": "NP_000757.2", "rna": "NM_000766.5"}, {"protein": "AAR90936.1", "rna": "AY513605.1"}, {"protein": "AAR90938.1", "rna": "AY513607.1"}, {"protein": "AAR90940.1", "rna": "AY513609.1"}]}, "alias": ["CPAD", "CYP2A", "CYPIIA13"], "ec": "1.14.14.1", "ensembl": {"gene": "ENSG00000197838", "protein": "ENSP00000332679", "transcript": "ENST00000330436", "translation": [{"protein": "ENSP00000332679", "rna": "ENST00000330436"}], "type_of_gene": "protein_coding"}, "entrezgene": "1553", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 14.7261864267, "exp_mis": 215.799659166, "exp_syn": 94.1317613031, "lof_z": 1.99438826434615, "mis_z": -0.572699901065476, "mu_lof": 9.784503322e-07, "mu_mis": 1.90818989886e-05, "mu_syn": 8.15918862032e-06, "n_lof": 7.0, "n_mis": 233.0, "n_syn": 77.0, "p_li": 0.00143445702978295, "p_null": 0.0330684072946982, "p_rec": 0.965497135675519, "syn_z": 1.09467030749041}, "bp": 1485, "cds_end": 41601846, "cds_start": 41594376, "n_exons": 9, "nonpsych": {"exp_lof": 13.1450643531, "exp_mis": 195.135966293, "exp_syn": 85.014776308, "lof_z": 2.20630291558941, "mis_z": -0.789446233026741, "mu_lof": 9.784503322e-07, "mu_mis": 1.90818989886e-05, "mu_syn": 8.15918862032e-06, "n_lof": 5.0, "n_mis": 217.0, "n_syn": 72.0, "p_li": 0.0244492660102739, "p_null": 0.016518205732586, "p_rec": 0.95903252825714, "syn_z": 0.888695684770242}, "nontcga": {"exp_lof": 13.5302001203, "exp_mis": 198.517809063, "exp_syn": 86.5833364888, "lof_z": 2.28764366666141, "mis_z": -0.582807428468972, "mu_lof": 9.784503322e-07, "mu_mis": 1.90818989886e-05, "mu_syn": 8.15918862032e-06, "n_lof": 5.0, "n_mis": 215.0, "n_syn": 71.0, "p_li": 0.0257491343359375, "p_null": 0.0126317616677999, "p_rec": 0.961619103996263, "syn_z": 1.0603900906729}, "transcript": "ENST00000330436.3"}, "exons": [{"cdsend": 41095941, "cdsstart": 41088471, "chr": "19", "position": [[41088450, 41088651], [41088928, 41089091], [41090046, 41090196], [41090403, 41090564], [41091731, 41091908], [41093629, 41093771], [41094244, 41094432], [41094958, 41095100], [41095759, 41096195]], "strand": 1, "transcript": "NM_000766", "txend": 41096195, "txstart": 41088450}], "exons_hg19": [{"cdsend": 41601846, "cdsstart": 41594376, "chr": "19", "position": [[41594355, 41594556], [41594833, 41594996], [41595951, 41596101], [41596308, 41596469], [41597636, 41597813], [41599534, 41599676], [41600149, 41600337], [41600863, 41601005], [41601664, 41602100]], "strand": 1, "transcript": "NM_000766", "txend": 41602100, "txstart": 41594355}], "generif": [{"pubmed": 12130698, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12130698, "text": "genetic polymorphism: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant"}, {"pubmed": 12920161, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 14633739, "text": "CYP2A13 allele is associated with reduced risk of lung adenocarcinoma, suggesting the role of NNK-CYP2A13 interaction as a causative factor for the cancer."}, {"pubmed": 14633739, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 15063809, "text": "In order to investigate the extent of CYP2A13 genetic polymorphism in a French Caucasian population of 102 individuals, a screening for sequence variations in the 5'-untranslated and protein encoding regions of its gene was performed."}, {"pubmed": 15063809, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15115698, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15115698, "text": "The CYP2A13 Arg257Cys variant represents a common polymorphism in Chinese, with the 257Cys allele frequency being similar to the Hispanic and Asian groups, but significantly lower than in blacks"}, {"pubmed": 15222883, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 15333516, "text": "CYP2A13 mutant proteins showed a significant decrease in the catalytic efficiency for NNK alpha-hydroxylation"}, {"pubmed": 16316926, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 16835796, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17428784, "text": "structure of CYP2A13 was determined to 2.35A by x-ray crystallography and compared with structures of CYP2A6."}, {"pubmed": 18669584, "text": "the reported association of the CYP2A13(*)2 allele with decreased incidences of lung adenocarcinoma in smokers can be at least partly explained by a decrease in CYP2A13 function"}, {"pubmed": 19290787, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 19303722, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 19343046, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19414505, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19789190, "text": "Observational study of gene-disease association, gene-gene interaction, and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19812523, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19812523, "text": "Observed clear prevalence of the variant CYP2A13 alelle causing premature stop at codon 101 (knockout allele *7) among the controls in comparison with the pancreatic cancer patients."}, {"pubmed": 20431511, "text": "The mechanisms underlying the decreased allelic expression of a common CYP2A13 allele (7520C>G) in the human lung, were investigated."}, {"pubmed": 20534012, "text": "2 novel polymorphisms T478C and T494C in CYP2A13 gene were associated with significantly reduced risk of cancer. CYP2A13 haplotype carrying variant alleles of T478C/T494C found associated with reduced risk of head/neck cancer."}, {"pubmed": 20534012, "text": "Observational study of gene-disease association, gene-gene interaction, and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20568895, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20798279, "text": "single nucleotide polymorphisms within the CYP2A13 gene affect metabolism of 5-methoxypsoralen in humans."}, {"pubmed": 20846153, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20846153, "text": "significant interaction between smoking and methylation status of CYP2A13 in head and neck cancer."}, {"pubmed": 21473878, "text": "present results provide the first direct in vitro evidence demonstrating the predominant roles of CYP2A13 in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced mutagenesis, possibly via metabolic activation of NNK alpha-hydroxylation"}, {"pubmed": 22315333, "text": "The distribution frequencies of all eight known CYP2A13 missense alleles were examined in a Chinese Han population."}, {"pubmed": 22397853, "text": "Tissue distribution of transgenic mRNA expression agrees well with the known respiratory tract-selective expression of CYP2A13 and CYP2F1 and hepatic expression of CYP2B6 in humans."}, {"pubmed": 22696418, "text": "Report CYP2A-selective inhibitors to accurately distinguish between CYP2A6 and CYP2A13 activity."}, {"pubmed": 22700965, "text": "Although both the hepatic CYP2A6 and respiratory CYP2A13 enzymes metabolize these compounds, CYP2A13 does so with much higher catalytic efficiency, but the structural basis for this has been unclear"}, {"pubmed": 22798551, "text": "Report selective expression of CYP2A13 in human pancreatic alpha-islet cells."}, {"pubmed": 22890016, "text": "The differential distribution pattern of CYP2A13 in the respiratory tract, which is of importance in considering the pulmonary susceptibility to carcinogens and the following lung cancer development, is detailed."}, {"pubmed": 23463547, "text": "an efficient approach for expressing functionally characterized, highly active and homogeneous CYP2A13 proteins."}, {"pubmed": 23583631, "text": "CYP2A13 plays an important role in low-concentration AFB1-induced DNA damage, possibly linking environmental airborne AFB1 to genetic injury in the human respiratory system."}, {"pubmed": 23602888, "text": "Findings suggest that CYP2A13 plays an important role in low-concentration AFB1-induced DNA damage, possibly linking environmental airborne AFB1 to genetic injury in human respiratory system."}, {"pubmed": 23752126, "text": "Findings suggest the potential involvement of pulmonary CYP2A13 in the early occurrence of NSCLC as well as in the development of EGFR gene mutations."}, {"pubmed": 23907605, "text": "Data suggest important role of CYP2A13 in AFG1- (aflatoxin G1)-induced cytotoxicity, DNA damage, and activation of signal pathways in bronchial epithelium; data suggest similarities in CYP2A13-catalyzed bioactivation of AFG1 and AFB1 (aflatoxin B1)."}, {"pubmed": 23917075, "text": "CYP2A13 is efficient in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in vivo and it can mediate 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis."}, {"pubmed": 24114584, "text": "CYP2A13 played a critical role in AFB1-induced neoplastic transformation."}, {"pubmed": 24907355, "text": "The transgenic CYP2A13 is active."}, {"pubmed": 25667220, "text": "an etiologically relevant interaction between CYP2A13 and ABCB1 associated with lung cancer was analysed"}, {"pubmed": 25710941, "text": "CYP2A13 levels in human lungs can be suppressed by disease-associated inflammation in tissue donors."}, {"pubmed": 27567546, "text": "CYP2A13 is the most efficient enzyme to metabolize N'-Nitrosonornicotine in vitro."}, {"pubmed": 27725446, "text": "The results of this case-control study suggested that the CYP2A13*1/*2 genotype decreased the risk of susceptibility to bladder cancer in Japanese smokers"}, {"pubmed": 28648140, "text": "Oxidation of 1-chloropyrene by human CYP1 family and CYP2A subfamily cytochrome P450 enzymes: catalytic roles of two CYP1B1 and five CYP2A13 allelic variants"}, {"pubmed": 29652224, "text": "Functional analysis of variations in P450 2A13 allelic variants may help to understand the consequences of P450 2A13 polymorphism in bioactivation of many tobacco-derived carcinogens."}, {"pubmed": 30807688, "text": "Study provides evidence that CYP2A13 gene polymorphisms may be candidate biomarkers of lung cancer susceptibility in Chinese."}, {"pubmed": 33327254, "text": "Association between CYP2A13 polymorphisms and lung cancer: A protocol for systematic review and meta-analysis."}, {"pubmed": 33703988, "text": "Molecular docking and oxidation kinetics of 3-phenyl coumarin derivatives by human CYP2A13."}, {"pubmed": 34830188, "text": "Genetic and Enzymatic Characteristics of CYP2A13 in Relation to Lung Damage."}], "genomic_pos": {"chr": "19", "end": 41096195, "ensemblgene": "ENSG00000197838", "start": 41088451, "strand": 1}, "genomic_pos_hg19": {"chr": "19", "end": 41602100, "start": 41594377, "strand": 1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0006805", "qualifier": "involved_in", "term": "xenobiotic metabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0009804", "qualifier": "involved_in", "term": "coumarin metabolic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0009804", "qualifier": "involved_in", "term": "coumarin metabolic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0019373", "qualifier": "involved_in", "term": "epoxygenase P450 pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0046222", "qualifier": "involved_in", "term": "aflatoxin metabolic process"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "is_active_in", "term": "cytoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005789", "qualifier": "located_in", "term": "endoplasmic reticulum membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0043231", "qualifier": "is_active_in", "term": "intracellular membrane-bounded organelle"}], "MF": [{"category": "MF", "evidence": "TAS", "id": "GO:0004497", "qualifier": "enables", "term": "monooxygenase activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005506", "qualifier": "enables", "term": "iron ion binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0008389", "qualifier": "enables", "term": "coumarin 7-hydroxylase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008392", "qualifier": "enables", "term": "arachidonic acid epoxygenase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0016712", "qualifier": "enables", "term": "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen"}, {"category": "MF", "evidence": "IBA", "id": "GO:0020037", "qualifier": "enables", "term": "heme binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0020037", "pubmed": 17428784, "qualifier": "enables", "term": "heme binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0070330", "qualifier": "enables", "term": "aromatase activity"}]}, "homologene": {"genes": [[6239, 183193], [8364, 496407], [8364, 496408], [8364, 548374], [8364, 100170416], [8364, 100486002], [8364, 100496861], [8364, 101730237], [9544, 678689], [9606, 1548], [9606, 1549], [9606, 1553], [10090, 13086], [10090, 13087], [10116, 24299]], "id": 85917}, "interpro": [{"desc": "Cytochrome P450", "id": "IPR001128", "short_desc": "Cyt_P450"}, {"desc": "Cytochrome P450, E-class, group I", "id": "IPR002401", "short_desc": "Cyt_P450_E_grp-I"}, {"desc": "Cytochrome P450, E-class, group I, CYP2A-like", "id": "IPR008067", "short_desc": "Cyt_P450_E_grp-I_CYP2A-like"}, {"desc": "Cytochrome P450, conserved site", "id": "IPR017972", "short_desc": "Cyt_P450_CS"}, {"desc": "Cytochrome P450 superfamily", "id": "IPR036396", "short_desc": "Cyt_P450_sf"}], "ipi": "IPI00003480", "map_location": "19q13.2", "name": "cytochrome P450 family 2 subfamily A member 13", "other_names": ["cytochrome P450 2A13", "cytochrome P450, family 2, subfamily A, polypeptide 13", "cytochrome P450, subfamily IIA (phenobarbital-inducible), polypeptide 13"], "pantherdb": {"HGNC": "2608", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "3648316", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 10090, "uniprot_kb": "B2RXZ2"}, {"MGI": "105055", "ortholog_type": "LDO", "panther_family": "PTHR24300", "taxid": 10090, "uniprot_kb": "P56593"}, {"RGD": "2464", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 10116, "uniprot_kb": "P15149"}, {"RGD": "2463", "ortholog_type": "LDO", "panther_family": "PTHR24300", "taxid": 10116, "uniprot_kb": "P11711"}, {"ZFIN": "ZDB-GENE-050522-490", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 7955, "uniprot_kb": "A0A0R4IKH1"}, {"dictyBase": "DDB_G0272704", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 352472, "uniprot_kb": "Q86A22"}, {"dictyBase": "DDB_G0286743", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 352472, "uniprot_kb": "Q54LA8"}, {"dictyBase": "DDB_G0282769", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 352472, "uniprot_kb": "Q1ZXG3"}, {"dictyBase": "DDB_G0282283", "ortholog_type": "O", "panther_family": "PTHR24300", "taxid": 352472, "uniprot_kb": "Q54SV9"}], "uniprot_kb": "Q16696"}, "pathway": {"kegg": [{"id": "hsa00980", "name": "Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human)"}, {"id": "hsa05204", "name": "Chemical carcinogenesis - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-211859", "name": "Biological oxidations"}, {"id": "R-HSA-211897", "name": "Cytochrome P450 - arranged by substrate type"}, {"id": "R-HSA-211935", "name": "Fatty acids"}, {"id": "R-HSA-211945", "name": "Phase I - Functionalization of compounds"}, {"id": "R-HSA-211981", "name": "Xenobiotics"}, {"id": "R-HSA-211999", "name": "CYP2E1 reactions"}, {"id": "R-HSA-5423646", "name": "Aflatoxin activation and detoxification"}], "smpdb": [{"id": "SMP00074", "name": "Retinol Metabolism"}, {"id": "SMP00336", "name": "Vitamin A Deficiency"}], "wikipathways": [{"id": "WP43", "name": "Oxidation by Cytochrome P450"}, {"id": "WP465", "name": "Tryptophan metabolism"}, {"id": "WP699", "name": "Aflatoxin B1 metabolism"}, {"id": "WP702", "name": "Metapathway biotransformation Phase I and II"}]}, "pdb": ["2P85", "2PG5", "2PG6", "2PG7", "3T3S", "4EJG", "4EJH", "4EJI"], "pfam": "PF00067", "pharmgkb": "PA27101", "pharos": {"target_id": 16071, "tdl": "Tchem"}, "pir": "I38966", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF248163", "relationship": "is"}, {"id": "GNF248164", "relationship": "is"}, {"id": "GNF248165", "relationship": "is"}, {"id": "GNF248166", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF064101", "relationship": "is"}, {"id": "GNF064102", "relationship": "is"}, {"id": "GNF065991", "relationship": "similar to"}], "NOVART_hs-genome_siRNA": [{"id": "GNF094012", "relationship": "is"}, {"id": "GNF133670", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000019.10", "NC_060943.1", "NG_007928.1"], "protein": "NP_000757.2", "rna": "NM_000766.5", "translation": {"protein": "NP_000757.2", "rna": "NM_000766.5"}}, "reporter": {"HG-U133_Plus_2": "208327_at", "HG-U95Av2": ["1338_s_at", "1552_i_at", "1553_r_at", "1554_f_at"], "HTA-2_0": "TC19000572.hg.1", "HuEx-1_0": ["3833948", "3862873", "3862944"], "HuGene-1_1": ["8028973", "8036969"], "HuGene-2_1": "16862397"}, "retired": [90330, 95745], "summary": "This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. Although its endogenous substrate has not been determined, it is known to metabolize 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a major nitrosamine specific to tobacco. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].", "symbol": "CYP2A13", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1413867"}, "unigene": "Hs.567252", "uniprot": {"Swiss-Prot": "Q16696"}, "wikipedia": {"url_stub": "CYP2A13"}}